Latest News and Press Releases

JSC “Grindeks” informs that it has received the Statement of “Grindeks” Chairman of the Board Juris Bundulis on his resignation from the position of Chairman of the Board starting from 21th of...

Akciju sabiedrība „Grindeks” plāno publicēt: nerevidētu 2019. gada 12 mēnešu finanšu pārskatu 2020. gada 28. februārī; nerevidētu 2020. gada 3 mēnešu finanšu pārskatu 2020. gada 29. maijā;...

JSC "Grindeks" plans to publish its: non-audited interim financial statement for the 12-month period of 2019 on 28 February 2020;non-audited interim financial statement for the 3-month period of 2020...

Akciju sabiedrība „Grindeks” informē, ka ir saņēmusi Saūda Arābijas Pārtikas un zāļu aģentūras sertifikātu, kas apliecina AS „Grindeks” gatavo zāļu formu – tablešu un kapsulu – ražotnes atbilstību...

JSC “Grindeks” informs that the company has received a certification of Saudi Food and Drug Authority certifying the compliance of “Grindeks” final dosage forms –tablets and capsules – with the Saudi...

2019. gada deviņos mēnešos „Grindeks” peļņa pieaug par 17% un sasniedz 8,9 milj. eiro Šodien, 28. novembrī, akciju sabiedrības „Grindeks” „Nasdaq Riga” iesniegtie 2019. gada deviņu mēnešu...

“Grindeks” profit in the first nine months of 2019 increases by 17% and reaches 8.9 million euro Today, on November 28, JSC “Grindeks” submitted the non-audited consolidated financial statements...

AS „Grindeks” informē, ka Pasaules Veselības organizācija (PVO) ir iekļāvusi medikamenta oksitocīna 10 SV/ml šķīduma injekciju Prekvalificēto Gatavo zāļu formu (GZF) sarakstā. „Grindeks” oksitocīns...

JSC “Grindeks” informs that World Health Organization (WHO) has included oxytocin solution for injection 10 IU/ml in the List of Prequalified Medicinal Products. “Grindeks” oxytocin in the List of...

“Grindeks” profit in the first six months of 2019 increases by 14% and reaches 7.65 million euro Today, on August 29, JSC “Grindeks” submitted the non-audited consolidated financial statements of...